Cerevel Therapeutics (CERE) News Today → Executive Order To Wipe Out Your Bank Accounts (From Oasis Gold) (Ad) Free CERE Stock Alerts $40.02 -0.24 (-0.60%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 8:55 AM | marketbeat.comWater Island Capital LLC Buys New Stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Water Island Capital LLC purchased a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 588,100 shares of the biotechnology company's stock, valued at approximatelyJune 8 at 5:12 AM | globenewswire.comCEREVEL NEWS NOTIFICATION: BFA Law Alerts Cerevel (Nasdaq: CERE) Shareholders of Investigation into the $45 Merger Offer, Contact the Firm About Your RightsJune 7 at 6:55 PM | marketbeat.comBain Capital Investors LLC Has $2.78 Billion Stock Holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Bain Capital Investors LLC lifted its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 65,679,781 shares of the biotechnology company's stock after purJune 6, 2024 | marketbeat.comGABELLI & Co INVESTMENT ADVISERS INC. Invests $11.68 Million in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 275,500 shares of the biotechnology company's stoJune 5, 2024 | globenewswire.comCEREVEL INVESTIGATION ALERT: Cerevel (Nasdaq: CERE) Investors are Encouraged to Contact BFA Law about the $45 Merger Offer from AbbVieJune 5, 2024 | marketbeat.comLake Street Advisors Group LLC Has $10.36 Million Stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Lake Street Advisors Group LLC grew its stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 191.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 244,309 shares of the biotechnology company'sJune 4, 2024 | marketbeat.comCarmignac Gestion Purchases Shares of 44,181 Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Carmignac Gestion acquired a new position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 44,181 shares of the biotechnology company's stock, valued at appJune 4, 2024 | seekingalpha.comCerevel Therapeutics: Time For A Risk Arbitrage Play?June 3, 2024 | globenewswire.comACQUISITION NEWS: Cerevel's (Nasdaq: CERE) $45 Merger Offer is Being Investigated for Being Too Low, Shareholders are Encouraged Contact BFA LawJune 2, 2024 | marketbeat.comShort Interest in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Grows By 7.7%Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Get Free Report) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 7,110,000 shares, a growth of 7.7% from the April 30th total of 6,600,000 shares. Based on an average daily volume of 1,150,000 shares, the short-interest ratio is presently 6.2 days. Approximately 8.1% of the shares of the stock are sold short.June 2, 2024 | marketbeat.com408,032 Shares in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Purchased by Hsbc Holdings PLCHsbc Holdings PLC acquired a new stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 408,032 shares of the biotechnology company's stock, valued at approximately $17,321,00June 1, 2024 | marketbeat.comNorges Bank Makes New $29.07 Million Investment in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Norges Bank acquired a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 685,694 shares of the biotechnology company'sMay 30, 2024 | marketbeat.comOlympiad Research LP Invests $2.01 Million in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Olympiad Research LP acquired a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 47,304 shares of the biotechnology company's stock, valued at apprMay 30, 2024 | prnewswire.comCEREVEL INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the FirmMay 29, 2024 | finance.yahoo.comPipeline for Acquisition Financing Shrinks, in Boon for CreditMay 29, 2024 | businesswire.comCalling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your LossesMay 26, 2024 | marketbeat.comCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Sold by Westfield Capital Management Co. LPWestfield Capital Management Co. LP decreased its holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 19.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 785,494 shares of the biotechnology company'sMay 23, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Grows Stock Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Charles Schwab Investment Management Inc. lifted its stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 25.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 649,333 shares of the biotMay 20, 2024 | marketbeat.com180,000 Shares in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Purchased by Kapitalo Investimentos LtdaKapitalo Investimentos Ltda acquired a new stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 180,000 shMay 20, 2024 | prnewswire.comNOTICE OF INVESTIGATION: Kaskela Law LLC Announces Shareholder Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the FirmMay 20, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Cerevel Therapeutics Holdings (CERE), Cullinan Management (CGEM) and Vincerx Pharma Inc (VINC)May 19, 2024 | morningstar.comCerevel Therapeutics Holdings Inc Ordinary Shares CEREMay 18, 2024 | stockhouse.comBFA LLP Reminds Cerevel Therapeutics Shareholders of the Investigation into Merger with AbbVie and Encourages Investors to Contact the FirmMay 16, 2024 | insidertrades.comN Anthony Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) StockMay 15, 2024 | stockhouse.comMERGER ALERT CERE Is $45 per CERE Share Fair? Top Law Firm BFA LLP Investigating Cerevel Therapeutics Merger with AbbVieMay 15, 2024 | insidertrades.comCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Director Sells $2,105,000.00 in StockMay 14, 2024 | marketbeat.comInsider Selling: Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Director Sells 50,000 Shares of StockCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Get Free Report) Director N Anthony Coles sold 50,000 shares of the company's stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $42.10, for a total value of $2,105,000.00. Following the sale, the director now owns 15,638 shares in the company, valued at approximately $658,359.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.May 11, 2024 | marketbeat.com108,657 Shares in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Purchased by Versor Investments LPVersor Investments LP bought a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 108,657 shares of the biotechnolMay 10, 2024 | marketbeat.comKellner Capital LLC Invests $861,000 in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Kellner Capital LLC bought a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 20,300 shares of the biotechnology company's stock, valued at appMay 9, 2024 | marketbeat.comSegantii Capital Management Ltd Buys Shares of 594,519 Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Segantii Capital Management Ltd purchased a new stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 594,519 shares of the biotechnology compaMay 6, 2024 | marketbeat.comBCK Capital Management LP Makes New Investment in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)BCK Capital Management LP bought a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 22,000 shares of the biotechnology company's stock, valued at approximately $933,May 5, 2024 | marketbeat.comInternational Assets Investment Management LLC Purchases Shares of 55,120 Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)International Assets Investment Management LLC acquired a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 55,120 shares of the biotechnology coApril 30, 2024 | finance.yahoo.comAddex stock tanks after lead drug flops in Phase II epilepsy trialApril 26, 2024 | finance.yahoo.comTop 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talksApril 22, 2024 | markets.businessinsider.comHold Rating Maintained for Cerevel Post-Positive Phase 3 Data Amid Pending AbbVie AcquisitionApril 20, 2024 | marketbeat.comCalamos Advisors LLC Makes New Investment in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Calamos Advisors LLC purchased a new position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 305,303 shares of the biotechnology company's stock, valApril 18, 2024 | benzinga.comSoon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease StudyApril 18, 2024 | msn.comAbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drugApril 18, 2024 | reuters.comCerevel Therapeutics' Parkinson's disease drug meets main goal in late-stage studyApril 18, 2024 | finance.yahoo.comCerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s DiseaseApril 18, 2024 | globenewswire.comCerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's DiseaseApril 16, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI) and Unity Biotechnology (UBX)April 12, 2024 | marketbeat.comCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Short Interest Up 38.2% in MarchCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 9,620,000 shares, a growth of 38.2% from the March 15th total of 6,960,000 shares. Based on an average daily trading volume, of 1,510,000 shares, the short-interest ratio is currently 6.4 days. Approximately 11.1% of the company's shares are sold short.April 12, 2024 | seekingalpha.comAbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67%April 11, 2024 | marketbeat.comInternational Assets Investment Management LLC Takes Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)International Assets Investment Management LLC purchased a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 55,120April 5, 2024 | investing.comCerevel Therapeutics director sells $2.12m in stock, buys $175k worthApril 3, 2024 | uk.finance.yahoo.comDirector N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)April 3, 2024 | marketbeat.comVanguard Group Inc. Purchases 708,826 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)Vanguard Group Inc. increased its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 12.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,371,376 shares of the biotechnology company's stockMarch 31, 2024 | marketbeat.com24,487 Shares in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Acquired by SG Americas Securities LLCSG Americas Securities LLC bought a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 24,487 shares of the biotechnology cMarch 29, 2024 | wsj.comCerevel Therapeutics Holdings Inc. Get Cerevel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter. Email Address It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution CERE Media Mentions By Week CERE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERE News Sentiment▼0.520.77▲Average Medical News Sentiment CERE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERE Articles This Week▼93▲CERE Articles Average Week Get Cerevel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CNX Resources News Today Warrior Met Coal News Today Arch Resources News Today Hallador Energy News Today Genmab A/S News Today Alnylam Pharmaceuticals News Today Teva Pharmaceutical Industries News Today Royalty Pharma News Today BioMarin Pharmaceutical News Today BeiGene News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERE) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored